9.200
−2,13%
2026-10-19
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -25.2% | -153.3% | 0 / 3 | +25.3% | -0.62 pp | +3.18 pp | -3.5% | 0.60 | — | 686 | +25,3% | 2,1 | +113,5% | — | 9.59 | — |
| Pts | 0 | 0 | 0 | 12 | 4 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 9.200 (close price on 2026-10-19)EPS (TTM): −1.329,3
Financial charts
1.Revenue & growth
VND bn686Q2/26
1.Revenue & growth
VND bn686Q2/26
2.Profit & growth
VND bn-27,4Q2/26
3.Profit mix (Penman)
VND bn17,0Q2/26
4.Margins & cost structure
%13.8%Q2/26
5.Returns & cash cycle
% · days7.4%Q2/26
6.Earnings quality & cash
VND bn614Q2/26
7.Asset structure
VND bn5.844Q2/26
8.Funding & debt health
VND bn · times5.844Q2/26
9.Revenue backlog
VND bn223Q2/26
10.Valuation
times · %-7,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-363Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-217%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26